FT Tech Tonic10 Des 2025

Defying death: The future of forever

Gene and stem cell therapies have been touted as the next phase in the longevity movement, with promises to rejuvenate the body at the cellular level and reverse the effects of ageing. But, as the prospect of life extension moves into the mainstream, it presents big questions for society as a whole. Are we ready for a world where people live much longer lives?

In this final episode, the FT’s Michael Peel and Hannah Kuchler dive into the tough moral questions at the heart of the longevity movement. Hannah speaks to the team at Fountain Life, a longevity clinic trying to bring stem cell therapy to the middle classes. We meet Daniel Ives, founder of gene therapy company Shift Bioscience, and Liz Parrish, who has self-experimented with gene therapies through her company, Biovia. Finally, Michael speaks to Arthur Caplan, the head of the ethics board of longevity fund, Hevolution.

Free to read:

From immortal jellyfish to elephants: scientists probe secrets of long-lived animals

Inside the billion-dollar quest to live beyond 100

Gene editing breakthrough promises to boost fight against disease

This series of Tech Tonic is hosted by Michael Peel and Hannah Kuchler. It is produced by Josh Gabert-Doyon. The senior producer is Edwin Lane. Flo Phillips is the executive producer. Sound design by Breen Turner and Samantha Giovinco. Fact checking by Simon Greaves, Lucy Baldwin and Tara Cromie. Original music by Metaphor Music. Manuela Saragosa is the FT’s acting co-head of audio. Special thanks to Michela Tindera.

Clips: Al Jazeera Balkans, TV France Japon, ABP News, Rome Reports, @Sciencerely

The FT does not use generative AI to voice its podcasts.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(261)

Rewiring sport: Hi-tech cheating

At the Enhanced Games in Las Vegas earlier this year, athletes used performance-enhancing drugs and banned equipment in an attempt to break world records. At the same time, companies such as Adidas ar...

15 Jul 29min

Rewiring sport: Is tech ruining sports fandom?

Video-assistant refereeing (VAR) has proved to be one of the most controversial pieces of technology ever introduced in sports. But with the rise of everything from broadcasting gimmicks to data-drive...

8 Jul 25min

Rewiring sport: How technology is helping athletes break barriers

For decades, sportspeople have been getting fitter, faster and reaching ever-higher levels of performance. But as the margin between winning and losing shrinks, athletes are turning to technology to m...

1 Jul 26min

Coming soon: Rewiring sport

Are technological advances in sport leaving athletes, fans and competition itself better off? Or are they undermining the spirit of sport? With the World Cup underway, the FT’s sports editor Josh Nobl...

24 Jun 57s

AI Labs: Zuckerberg’s $100bn gamble

Mark Zuckerberg created the world’s biggest social media company in Facebook, before deciding the future lay in the metaverse. Now he’s spending hundreds of billions of dollars to transform Meta again...

3 Jun 28min

AI Labs: Elon Musk wants AI in space

Elon Musk’s xAI is lagging behind the likes of OpenAI and Google DeepMind in the AI race. Will a giant IPO of SpaceX, Musk’s rocket company, change all that? Murad Ahmed speaks to FT technology corres...

27 Mai 24min

AI Labs: Sam Altman may make or break OpenAI

OpenAI sparked the generative AI boom with the release of ChatGPT. But along the way its chief executive Sam Altman has ruffled plenty of feathers. Colleagues have left to set up rival labs, co-founde...

20 Mai 28min

AI Labs: Google DeepMind plans its comeback

In the latest AI boom Google has been playing catch-up with the likes of OpenAI and Anthropic. But with stacks of cash, its own AI chips and some of the best AI talent in the world, is Google about to...

13 Mai 29min